Search Results
Symposium On: Residual CV Risk: IS LDL-C Target Enough?
Optimizing Lipid Risk Factors: Focus on Residual Risk, Dr. David Vorchheimer
Optimizing Lipid Risk Factors: Focus on Residual Risk
What is their relevance to residual macrovascular risk when LDL-C is low?
Advanced Lipoprotein Testing: Is Knowing Your LDL Cholesterol Enough?
Lipid Management; What's NEW?
CV Risk in Statin-Treated Patients with Elevated Triglycerides (Deepak L Bhatt, MD) November 7, 2019
Lipid Disorders Webinar
Eckel Invited Lecture: Evaluating and Treating "Residual Risk" in ASCVD | Michael J. Blaha, MD, MPH
NIH Obesity Research Task Force Symposium: Obesity and Heart Disease Webinar
New Guidelines in Dyslipidemia
Dr Erin Bohula May - 'At the limits of lipid management – statins to PCSK9 inhibitors'
